{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:23:57Z","timestamp":1790717037779,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1378\/chest.11-3241","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T16:42:26Z","timestamp":1359045746000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"144","author":[{"given":"Abby D.","family":"Poms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"McGoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1378\/chest.11-3241_bib1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(11)60769-6","article-title":"Design of the REVEAL registry for US patients with pulmonary arterial hypertension","volume":"83","author":"McGoon","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"suppl 1","key":"10.1378\/chest.11-3241_bib2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"10.1378\/chest.11-3241_bib3","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1378\/chest.11-3241_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1378\/chest.11-3241_bib5","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"issue":"1 suppl","key":"10.1378\/chest.11-3241_bib6","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","article-title":"Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McLaughlin","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.11-3241_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the US-based REVEAL Registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.11-3241_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1378\/chest.11-0676","article-title":"The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension","volume":"141","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"16","key":"10.1378\/chest.11-3241_bib9","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2010.31.3353","article-title":"Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model","volume":"29","author":"Naqvi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1378\/chest.11-3241_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jnci\/djr188","article-title":"The influence of comorbidities on overall survival among older women diagnosed with breast cancer","volume":"103","author":"Patnaik","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1378\/chest.11-3241_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.00203809","article-title":"Efficacy of standard rehabilitation in COPD outpatients with comorbidities","volume":"36","author":"Crisafulli","year":"2010","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1378\/chest.11-3241_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00408-009-9222-y","article-title":"Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study","volume":"188","author":"Terzano","year":"2010","journal-title":"Lung"},{"issue":"1","key":"10.1378\/chest.11-3241_bib13","first-page":"58","article-title":"Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life","volume":"31","author":"Rupp","year":"2004","journal-title":"J Rheumatol"},{"issue":"suppl 1","key":"10.1378\/chest.11-3241_bib14","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.mcp.0000370208.45756.e8","article-title":"Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease","volume":"16","author":"Coghlan","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"suppl 2","key":"10.1378\/chest.11-3241_bib15","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report. National Institutes of Health","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"key":"10.1378\/chest.11-3241_bib16","unstructured":"US National Institutes of Health. A multicenter, double-blind, placebo-controlled phase 3 study to demonstrate the efficacy and safety of ACT-293987 in patients with pulmonary arterial hypertension. NCT01106014. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2010. http:\/\/clinicaltrials.gov\/show\/NCT01106014. Updated October 8, 2012."},{"key":"10.1378\/chest.11-3241_bib17","unstructured":"US National Institutes of Health. Long-term single-arm open-label extension study of the SERAPHIN Study, to assess the safety and tolerability of ACT 064992 in patients with symptomatic pulmonary arterial hypertension. NCT00667823. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2008. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT006678230. Updated October 23, 2012."},{"key":"10.1378\/chest.11-3241_bib18","unstructured":"US National Institutes of Health. A 16-week, international, multicenter, double-blind, randomized, placebo-controlled comparison of the efficacy and safety of oral UT-15C sustained release tablets in combination with an endothelin receptor antagonist and\/or a phosphodiesterase-5 inhibitor in subjects with pulmonary arterial hypertension. NCT00325442. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2006. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00325442. Updated January 18, 2012."},{"issue":"2","key":"10.1378\/chest.11-3241_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4065\/mcp.2010.0394","article-title":"Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey","volume":"86","author":"Burger","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1378\/chest.11-3241_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1510\/icvts.2010.256677","article-title":"The obesity paradox in elderly obese patients undergoing coronary artery bypass surgery","volume":"13","author":"Le-Bert","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"6","key":"10.1378\/chest.11-3241_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1212\/WNL.0b013e31820b7667","article-title":"Paradoxical longevity in obese patients with intracerebral hemorrhage","volume":"76","author":"Kim","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1378\/chest.11-3241_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/STROKEAHA.110.593434","article-title":"Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox","volume":"42","author":"Vemmos","year":"2011","journal-title":"Stroke"},{"issue":"suppl 5","key":"10.1378\/chest.11-3241_bib23","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1055\/s-0029-1225315","article-title":"Pulmonary hypertension in COPD and interstitial lung diseases [in German]","volume":"134","author":"Markart","year":"2009","journal-title":"Dtsch Med Wochenschr"},{"issue":"5","key":"10.1378\/chest.11-3241_bib24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacc.2011.03.033","article-title":"Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes","volume":"58","author":"Lowe","year":"2011","journal-title":"J Am Coll Cardiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921360464X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236921360464X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:57:06Z","timestamp":1762124226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236921360464X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S001236921360464X"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-3241","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-3241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}